Session

IBD (Posters)

ACUTE SEVERE ULCERATIVE COLITIS: IS THE NEW SCORE PROPOSED BY ACG BETTER TO PREDICT TREATMENT OUTCOMES?
ACUTE SEVERE ULCERATIVE COLITIS: IS THE NEW SCORE PROPOSED BY ACG BETTER TO PREDICT TREATMENT OUTCOMES?

IBD (Posters)  et al.

CLOSTRIDIUM DIFFICILE INFECTION IN IBD PATIENTS HOSPITALIZED IN A TERTIARY CENTER
CLOSTRIDIUM DIFFICILE INFECTION IN IBD PATIENTS HOSPITALIZED IN A TERTIARY CENTER

IBD (Posters)  et al.

FIRST-LINE AZATHIOPRINE WITH ALLOPURINOL CO-THERAPY IS A PROMISING LONG-TERM TREATMENT STRATEGY FOR INFLAMMATORY BOWEL DISEASES
FIRST-LINE AZATHIOPRINE WITH ALLOPURINOL CO-THERAPY IS A PROMISING LONG-TERM TREATMENT STRATEGY FOR INFLAMMATORY BOWEL DISEASES

IBD (Posters)  et al.

DUBLIN SCORE: AN ENDOSCOPIC SCORE TO QUANTIFY INFLAMMATORY ACTIVITY IN ULCERATIVE COLITIS
DUBLIN SCORE: AN ENDOSCOPIC SCORE TO QUANTIFY INFLAMMATORY ACTIVITY IN ULCERATIVE COLITIS

IBD (Posters)  et al.

SYMPTOMATOLOGY AND QUALITY OF LIFE IN INFLAMMATORY BOWEL DISEASE. IS THERE A GOOD CORRELATION BETWEEN THEM AND INFLAMMATORY ACTIVITY?
SYMPTOMATOLOGY AND QUALITY OF LIFE IN INFLAMMATORY BOWEL DISEASE. IS THERE A GOOD CORRELATION BETWEEN THEM AND INFLAMMATORY ACTIVITY?

IBD (Posters)  et al.

NOVEL INSIGHT INTO MECHANISM OF HEALING OF EXPERIMENTAL COLITIS BY INTESTINAL ALKALINE PHOSPHATASE IN OBESE MICE SUBJECTED TO FORCED TREADMILL EXERCISE. INVOLVEMENT OF OXIDATIVE STRESS, PROINFLAMMATORY BIOMARKERS AND INTESTINAL BARRIER PROTEINS
NOVEL INSIGHT INTO MECHANISM OF HEALING OF EXPERIMENTAL COLITIS BY INTESTINAL ALKALINE PHOSPHATASE IN OBESE MICE SUBJECTED TO FORCED TREADMILL EXERCISE. INVOLVEMENT OF OXIDATIVE STRESS, PROINFLAMMATORY BIOMARKERS AND INTESTINAL BARRIER PROTEINS

IBD (Posters)  et al.

PECTIN-COATED AC2-26-LOADED NANOPARTICLES FACILITATE ANASTOMOTIC HEALING IN A MURINE MODEL OF COLONIC SURGERY DURING EXPERIMENTAL COLITS
PECTIN-COATED AC2-26-LOADED NANOPARTICLES FACILITATE ANASTOMOTIC HEALING IN A MURINE MODEL OF COLONIC SURGERY DURING EXPERIMENTAL COLITS

IBD (Posters)  et al.

PILLCAM CROHN'S CAPSULE - THE USE OF A PANENTERIC CAPSULE ENDOSCOPY IN A PORTUGUESE CENTER
PILLCAM CROHN'S CAPSULE - THE USE OF A PANENTERIC CAPSULE ENDOSCOPY IN A PORTUGUESE CENTER

IBD (Posters)  et al.

COVID-19 OUTBREAK IMPACTING QUALITY OF LIFE AND SELF-PERCEIVED STRESS IN INFLAMMATORY BOWEL DISEASE
COVID-19 OUTBREAK IMPACTING QUALITY OF LIFE AND SELF-PERCEIVED STRESS IN INFLAMMATORY BOWEL DISEASE

IBD (Posters)  et al.

COLORECTAL CANCER RISK IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH HIGH-GRADE DYSPLASIA: A SYSTEMATIC REVIEW AND META-ANALYSIS
COLORECTAL CANCER RISK IN INFLAMMATORY BOWEL DISEASE PATIENTS WITH HIGH-GRADE DYSPLASIA: A SYSTEMATIC REVIEW AND META-ANALYSIS

IBD (Posters)  et al.

DIAGNOSTIC AND PROGNOSTIC VALUES OF ANTI-GLYCOPROTEIN 2 ANTIBODIES (GP2A) IN INFLAMMATORY BOWEL DISEASES: RESULTS OF A RETROSPECTIVE MONOCENTRIC COHORT STUDY
DIAGNOSTIC AND PROGNOSTIC VALUES OF ANTI-GLYCOPROTEIN 2 ANTIBODIES (GP2A) IN INFLAMMATORY BOWEL DISEASES: RESULTS OF A RETROSPECTIVE MONOCENTRIC COHORT STUDY

IBD (Posters)  et al.

INCREASED RELAPSE RATE AFTER DISCONTINUATION OF IMMUNOMODULATOR MONOTHERAPY BUT NOT AFTER WITHDRAWAL FROM COMBINATION REGIMEN IN INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS
INCREASED RELAPSE RATE AFTER DISCONTINUATION OF IMMUNOMODULATOR MONOTHERAPY BUT NOT AFTER WITHDRAWAL FROM COMBINATION REGIMEN IN INFLAMMATORY BOWEL DISEASE: A SYSTEMATIC REVIEW AND META-ANALYSIS

IBD (Posters)  et al.

SWITCHING OUT OF CLASS IS THE MOST EFFECTIVE STRATEGY IN IBD PATIENTS WITH IMMUNOGENICITY AGAINST ANTI-TNF ANTIBODIES
SWITCHING OUT OF CLASS IS THE MOST EFFECTIVE STRATEGY IN IBD PATIENTS WITH IMMUNOGENICITY AGAINST ANTI-TNF ANTIBODIES

IBD (Posters)  et al.

COMPARISON OF SERUM ADALIMUMAB TROUGH LEVELS IN 40MG WEEKLY VS 80MG EVERY TWO WEEKS INTENSIFICATION REGIMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE
COMPARISON OF SERUM ADALIMUMAB TROUGH LEVELS IN 40MG WEEKLY VS 80MG EVERY TWO WEEKS INTENSIFICATION REGIMES IN PATIENTS WITH INFLAMMATORY BOWEL DISEASE

IBD (Posters)  et al.

RISK FACTORS FOR POOR POSTOPERATIVE OUTCOME IN PATIENTS WITH CROHN'S DISEASE UNDERGOING ILEOCECAL RESECTION
RISK FACTORS FOR POOR POSTOPERATIVE OUTCOME IN PATIENTS WITH CROHN'S DISEASE UNDERGOING ILEOCECAL RESECTION

IBD (Posters)  et al.

POST-OPERATIVE COURSE OF CROHN´S DISEASE AFTER ILEOCAECAL RESECTION: RESULTS OF A RETROSPECTIVE MONOCENTRIC COHORT STUDY
POST-OPERATIVE COURSE OF CROHN´S DISEASE AFTER ILEOCAECAL RESECTION: RESULTS OF A RETROSPECTIVE MONOCENTRIC COHORT STUDY

IBD (Posters)  et al.

PREVALENCE AND PREDICTIVE FACTORS OF FATIGUE IN INFLAMMATORY BOWEL DISEASE PATIENTS IN REMISSION
PREVALENCE AND PREDICTIVE FACTORS OF FATIGUE IN INFLAMMATORY BOWEL DISEASE PATIENTS IN REMISSION

IBD (Posters)  et al.

GASTROINTESTINAL TOXICITY DUE TO IMMUNE CHECKPOINT INHIBITORS: CLINIC EXPERIENCE IN A TERTIARY REFERRAL HOSPITAL
GASTROINTESTINAL TOXICITY DUE TO IMMUNE CHECKPOINT INHIBITORS: CLINIC EXPERIENCE IN A TERTIARY REFERRAL HOSPITAL

IBD (Posters)  et al.

Item 541 - 558 / 558
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27
28